Redefining breast cancer: therapeutic opportunities in HER2-low and emerging molecular subtypes. - Shadab A; Al-Shdefat RIK (Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026)